Kicking things off with Saturday Night Live announcing their hosts and musical guests for March. After a huge 50th ...

She-Hulk: Attorney at Law star Tatiana Maslany has commented briefly on what her MCU future looks like, suggesting she could ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast. Sales ...

The event will feature speakers from General Atlantic, PIF, Scrum Ventures, Mantis, Mindvalley, and LeapFrog Investments. The Investor Stage will cover themes related to technology investment ...

As LEAP 2025 prepares to return to the Saudi capital, it is debuting a new initiative aimed at offering attendees a deeper connection to Riyadh’s rich heritage and cutting-edge tech scene.

WASHINGTON (AP) — New Attorney General Pam Bondi on Wednesday ordered a review of the federal prosecution of Donald Trump as she unveiled a series of directives designed to overhaul a Justice ...

If you're looking for all the new Batman comics, then you're in the right place! The Dark Knight is more than just a superhero – he's a true pop culture icon. Every month DC publishes a host of ...

Batman: Arkham Shadow has reached over one million players. The VR exclusive was released in October 2024 for Meta Quest 3 and Meta Quest 3S headsets. Batman's Arkhamverse has always implemented ...

Thank you dear subscribers, we are overwhelmed with your response. Your Turn is a unique section from ThePrint featuring points of view from its subscribers. If you ...

Lastly, DeepSeek has opened up the AI race, and here’s why India can leapfrog into the future. With Union Budget 2025 on the horizon, stakeholders from across industries are eagerly awaiting ...

ARTIFICIAL Intelligence (AI) propels modern technology, reshaping industries and national strategies alike. Though the US and Silicon Valley once dominated AI innovation, China’s AI ecosystem ...

Leap Therapeutics has come crashing down to earth. The biotech axed plans to advance into phase 3 in gastric cancer on the basis of midstage data, sending its stock down 60% to below $1, but it is ...